|
Match
|
Document |
Document Title |
|
|
5141953 |
Purpuromycin for the treatment of vaginal infections and pharmaceutical dosage forms for said use
Use of the antibiotic purpuromycin for the topical treatment of infectious vaginitis and topical dosage forms containing said product. The antibiotic purpuromycin is simultaneously active against...
|
|
|
5141942 |
Pharmaceutical compositions comprising labdane diterpenoid derivatives and pyrimido(6,1-a)isoquinolin-4-one derivatives and their use
Pharmaceutical compositions comprising labdane diterpenoid derivatives and pyrimido(6,1-a)-isoquinolin-4-one derivatives when administered to the skin of a mammal or of the man increase the rate of...
|
|
|
5139940 |
Activation compounds and methods of synthesis of activation compounds
The invention is directed to isopsoralen compound compositions that contain a variety of substitutions which yet permit their binding to nucleic acid polymers. Reaction conditions that activate...
|
|
|
5118705 |
Water soluble salts of purpuromycin and pharmaceutical formulations thereof
Water soluble salts of purpuromycin, their use for the topical treatment of infectious vaginitis and topical dosage forms containing said products. Oral and parenteral formulations for...
|
|
|
5118494 |
Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
Pharmaceutical suspension aerosol formulations using one or more perfluorinated carboxylic acids or esters thereof as surface-active dispersing agents and 1,1,1,2-tetra-fluorethane or...
|
|
|
5116864 |
Method for preventing restenosis following reconfiguration of body vessels
Restenosis following vascular recanalization is prevented by administering a photoactivatable psoralen and, in conjunction with recanalization, delivering ultraviolet radiation to the region of...
|
|
|
5114721 |
Preparation of T-cell and T-cell membrane for use in prevention and treatment of autoimmune diseases
Pharmaceutical preparations are provided for preventing or treating autoimmune diseases in which the active principle is activated T-lymphocyte cells, specific for the autoimmune disease to be...
|
|
|
5104894 |
Ellagic acid analogues
Synthetic novel ellagic acid congeners of the formula: ##STR1## wherein: R 1 is --H, --OH or --OR'; R 2 is --H, --OH or --OR'; R 3 is --H, --OH or --OR'; R 4 is --H, --OH or --OR'; ...
|
|
|
5093106 |
Method for contrasting malignant neoplasms using fluorescein and a sugar
The present invention is used for diagnosis, including early diagnosis, of malignant growths, for assessment as of the extent of malignant infection, for determining of the required volume for...
|
|
|
5093331 |
Labdane derivatives, a process for their preparation, and their use as medicaments
The present invention relates to polyoxygenated labdane-derivatives of the formula ##STR1## a process for their preparation and the use of these substances as medicaments, preferably as medicaments...
|
|
|
5071853 |
Polycyclic amines useful as cerebrovascular agents
A novel series of polycyclic amines, derivatives, methods of making the compounds, novel intermediates, compositions containing them, and methods for using them in the treatment and prevention of...
|
|
|
5047412 |
Alkene derivatives
The invention describes novel (2-styryl-, 2-naphthyl- and 2-phenethyl-4-o-hydroxyphenyl-1,3-dioxan-5-yl)alkenoic acids and related tetrazoles and sulphonamides, of the formula I wherein Q completes...
|
|
|
5043350 |
Benzo-fused cycloalkane and oxa- and thia-, cycloalkane trans-1,2-diamine derivatives
Benzo-fused cycloalkane and oxa- and thia- cycloalkane trans-1,2-diamine compounds of the formula: ##STR1## wherein A, B, C, D, n, X, Y, R, R 1 , R 2 and R 3 are as defined in the specification,...
|
|
|
5036102 |
Method of treating autoimmune diseases comprising administration of psoralen dosage forms
A method of treating leukocyte mediated autoimmune and skin diseases using psoralen reagent composition comprising sterile aqueous solutions suitable for extracorporeal administration to blood from...
|
|
|
5032591 |
Pharmaceutical preparations
A pharmaceutical product comprising a potassium channel activator antihypertensive agent and a β-blocker antihypertensive agent as a combined preparation for simultaneous, separate or sequential...
|
|
|
5023270 |
Antidepressant method of use
This invention concerns a pharmaceutical composition useful for treating depression in humans, comprising an effective amount of 5-methoxypsoralen, and optionally, a suitable carrier or diluent,...
|
|
|
5017368 |
Composition for application to hair or scalp
A composition for application to hair or scalp comprises (A) at least one compound selected from the group consisting of (i) forskolin and derivatives thereof and (ii) peptides having a basic...
|
|
|
5017603 |
Xanthomegnin, a known compound, is an antiparasitic agent
The controlled aerobic fermentation of the fungal organism Fusarium lateritium var. longum produces xanthomegnin. Xanthomegnin has been discovered to have potent parasiticidal, anthelminthic, and...
|
|
|
4999378 |
Phenylcarboxylic acid derivatives
Phenylcarboxylic acid derivatives having the formula: ##STR1## wherein R 1 and R 2 are each H, halogen, alkyl, haloalkyl, alkanoyl, cycloalkyl, nitro, amino, --O--D--R 5 (D is alkylene, R 5 is...
|
|
|
4999375 |
Psoralen reagent compositions for extracorporeal treatment of blood
Psoralen compositions for extracorporeal administration to blood prior to reinfusion into a subject comprising a sterile aqueous solution of about 0.005 to about 1 mg/ml of a psoralen ethyl...
|
|
|
4987150 |
Agent for inhibiting binding of 5-dihydro-testosterone with androgen receptor as well as process for obtaining same
An agent for inhibiting the binding of 5α-dihydrotestosterone with androgen receptor, which comprises at least one extract from herbs or one of specific xanthone compounds, and a process for...
|
|
|
4983625 |
Psoralene-based bath compositions for treatment of skin disorders
A bath composition for the treatment of psoriasis or other cutaneous disorders contains from 10-79.9 weight percent of a hydrophilic phase, from 20-89.9 weight percent of a fatty or lipophilic...
|
|
|
4963581 |
Naphthopyran derivatives and use thereof
The present invention relates to an aromatase inhibiting composition which contains a compound of the formula: ##STR1## wherein R is hydroxy, lower alkoxy or amino which may be substituted by lower...
|
|
|
4963537 |
Labdane compounds, pharmaceutical compositions and use
Novel labdanes, intermediates and processes for the preparation thereof, and methods for reducing intraocular pressure utilizing compounds or compositions thereof are disclosed.
|
|
|
4939167 |
Use of 5-methoxypsoralen and other furocoumarins as jet lag suppressants
Disclosed is use of 5-methoxypsoralen to prevent and suppress the symptons of jet lag.
|
|
|
4927849 |
Sulfonamido derivatives inhibiting the aldose reductase enzyme system and pharmaceutical compositions containing them
The xanthosulfonamido and benzensulfonamido derivatives corresponding to the formula: ##STR1## wherein x represents hydrogen, alkyl, alkoxy or halogen, Y represents an alkyl, alkoxy or halogen and...
|
|
|
4920146 |
Carbamoyloxylabdane compounds useful in reducing intraocular pressure
Novel carbamoyloxylabdanes, intermediates and processes for the preparation thereof, and methods for reducing intraocular pressure and treating cardiac failure utilizing compounds and compositions...
|
|
|
4913901 |
Pharmaceutical composition for oral administration and process for the use thereof
An orally administrable and stable solution containing as an active ingredient Methoxasalen (8-methoxyfuro-[3',-2':6,7]-coumarin) of the formula ##STR1## useful in the photochemotherapy of...
|
|
|
4883793 |
Hydrazinocarbonyloxylabdanes for treating cardiac failure
Novel hydrazinocarbonyloxylabdanes, intermediates and processes for the preparation thereof, and a method for treating cardiac failure utilizing compounds or compositions thereof are disclosed.
|
|
|
4882350 |
Derivatives of 1-benzyl-2-oxo-5-alkoxy-pyrrolidine, and medicament compositions containing them
Compounds useful in the treatment of patients suffering from intellectual or nervous asthenias, memory failures, senescence or metal strain of the formula (I) ##STR1## in which R' represents...
|
|
|
4853410 |
Hydroxyacetic acid derivatives for the treatment of diabetic complications
Racemic and chiral (2R,4R)-4-c-hydroxy-2-4-(substituted)chroman(and thiochroman)-4-acetic acids and their pharmaceutically acceptable salts, their use in the treatment of diabetic complications and...
|
|
|
4847290 |
Delta 1-thc-7-oic acid and analgesic and anti-inflammatory agents
A non-psychoactive metabolite of THC is described. The invention is based on the discovery that this metabolite has analgesic and anti-inflammatory properties. The use of the metabolite as a...
|
|
|
4845121 |
Aci-reductone compounds belonging to the 6,7-disubstituted-3,4-dihydro benzopyan-2H-one class having antiaggregatory properties
The present invention relates to novel benzopyranone aci-reductone compounds of the formula I wherein X and Y are selected from the group comprising H (except that X and Y are not both H, unless...
|
|
|
4816479 |
Xanthone derivatives and process for producing the same
Xanthone derivatives of the formula (I): ##STR1## wherein W, X, Y and Z which may be the same or different represent a hydrogen atom, a halogen atom or a lower alkyl group having 1 to 4 carbon...
|
|
|
4782082 |
Method for treating allergic reactions with Forskolin
Forskolin and its disclosed derivatives are useful as antiallergic agents. Certain of the derivatives are novel.
|
|
|
4772603 |
Method for treating congestive heart failure, angina, occlusive peripheral vascular disease or cerebral vascular disease in mammals
A method for the treatment and/or prophylaxis of congestive heart failure, angina, occlusive peripheral vascular disease or cerebral vascular disease in mammals, such as humans, which method...
|
|
|
4751224 |
Treatment of metastasis
A method for reducing the incidence of metastasis in tumor victims without treating the primary tumor per se resides in the administration of forskolin or its analogs which are potent inhibitors of...
|
|
|
4740522 |
Oxolabdanes useful as pharmaceuticals for reducing intraocular pressure
Novel oxolabdanes, intermediates and processes for the preparation thereof, and methods for reducing intraocular pressure utilizing compounds or compositions thereof are disclosed.
|
|
|
4724238 |
Method of treating inflammatory diseases with labdan derivatives
The present invention relates to a process for the isolation of labdan derivatives from the plant Coleus forskohlii, and their use as medicaments having anti-inflammatory and analgesic activity.
|
|
|
4670452 |
Dioxo dibenzopyrans and anti-allergic use thereof
There are provided benzopyrans of formula I ##STR1## wherein R 6 and R 7 together form the chain --CHOCH(A 1 E 1 )--O-- in which --O-- is attached to R 7 , R 5 represents hydrogen, R 8...
|
|
|
4639446 |
Aminoacyllabdanes, pharmaceutical compositions and use
Novel aminoacyllabdanes, intermediates and processes for the preparation thereof, and methods for reducing intraocular pressure utilizing compounds or compositions thereof are disclosed.
|
|
|
4626432 |
Storage of red blood cells
Use of compounds of formula (I) ##STR1## to provide a more effective delivery of oxygen to the tissues of a mammalian, including human, recipient. In vivo applications include the relief or...
|
|
|
4578399 |
Use of the diterpene derivative forskolin for immunostimulation
The possibility of using the diterpene derivative forskolin (1α, 6β, 9α-trihydroxy-7β-acetoxy-8,13-epoxy-14-labden-11-one) to increase the immunological responsiveness of mammals is described.
|
|
|
4571405 |
Anti-allergic chromone- or thiochromone-5-oxamic acid derivatives, compositions, and method of use therefor
Certain 5-substituted chromones and thiochromones and pharmacologically acceptable salts thereof are disclosed. The compounds possess antiallergic properties and are represented by the formula:...
|
|
|
4564626 |
Methods of inducing bronchodilation
A method for producing bronchodilation in a mammal is disclosed. Composition for use in said method are also described.
|
|
|
4556651 |
Secalonic acid derivatives as antitumor agents
A secalonic acid derivative of the formula (I); ##STR1## wherein R is ##STR2## wherein R 1 and R 2 each independently is a hydrogen atom or a C 1 -4 alkyl group; R 3 is a hydrogen atom, a C 1 -4...
|
|
|
4476140 |
Composition and method for treatment of glaucoma
Topical administration of one of the polyoxygenated Labdanes of which forskolin is an example to the eyes produces lower intraocular pressure. The topical application to the eye produces no...
|
|
|
4454152 |
Methoxsalen dosage forms
This invention relates to oral dosage forms wherein the active ingredient, methoxsalen, is dispersed in a water-soluble composition containing a polyethylene glycol or mixtures of polyethylene...
|
|
|
4382952 |
Antibiotic roridin L-2 and its use
The present invention relates to a novel trichothecene antibiotic, roridin L-2, and a process for the production and the method of using said compound.
|
|
|
4376123 |
Hexahydroazepinyloxy-chromones useful as antidepressants
Basic ethers of the formula ##STR1## wherein Z is CH 3 --NR 2 --CH 2 CH 2 --CHR 1 --, (1-R 2 -3-piperidyl)-CHR 3 --, (1-R 2 -2-piperidyl)-CH 2 --CHR 3 - or 1-R 2 -3-R 4 ...
|